Bevacizumab Combination Therapy: For the First-Line Treatment of Advanced Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

By Dhillon Sohita  

Drugs, Vol. 72, Iss. 7, 2012-05 ,pp. : 917-930

Adis International

Access to resources Recommend Favorite

A Parenteral Econazole Formulation Using a Novel Micelle-to-Liposome Transfer Method: In Vitro Characterization and Tumor Growth Delay in a Breast Cancer Xenograft Model

By Cogswell Sebastian   Berger Stuart   Waterhouse Dawn   Bally Marcel   Wasan Ellen  

Pharmaceutical Research, Vol. 23, Iss. 11, 2006-11 ,pp. : 2575-2585

Springer Publishing Company

Access to resources Recommend Favorite

A Microsphere-Liposome (Microplex) Vector for Targeted Gene Therapy of Cancer. II. In Vivo Biodistribution Study in a Solid Tumor Model

By Dass Crispin R.   Walker Todd L.   Kalle Wouter H. J.   Burton Mark A.  

Drug Delivery, Vol. 7, Iss. 1, 2000-03 ,pp. : 15-19

Informa Healthcare

Access to resources Recommend Favorite

Combination therapy with the albumin-binding prodrug of doxorubicin (INNO-206) and doxorubicin achieves complete remissions and improves tolerability in an ovarian A2780 xenograft model

By Kratz Felix  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1743-1749

Springer Publishing Company

Access to resources Recommend Favorite

Toward operative in vivo fluorescence imaging of the c-Met proto-oncogene for personalization of therapy in ovarian cancer

By Liu Shujuan   Zheng Yong   Volpi Davide   El-Kasti Muna   Klotz Daniel   Tullis Iain   Henricks Andrea   Campo Leticia   Myers Kevin   Laios Alex   Thomas Peter   Ng Tony   Dhar Sunanda   Becker Christian   Vojnovic Borivoj   Ahmed Ahmed Ashour  

Cancer, Vol. 121, Iss. 2, 2015-01 ,pp. : 202-213

Blackwell Publishing

Access to resources Recommend Favorite